MFIMFI
AMPH icon

Mesirow Financial Investment Management - Fixed Income’s Amphastar Pharmaceuticals AMPH Stock Holding History

Mesirow Financial Investment Management - Fixed Income’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-341,294
Closed -$11.9M – 14
2022
Q2 		$11.9M Buy
341,294
+89,635
+36% +$3.2M 1.52% 9
2022
Q1 		$9.04M Buy
+251,659
New +$7.14M 1% 46

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Mesirow Financial Investment Management - Fixed Income's AMPH Position: Q3 2022 in Review

Mesirow Financial Investment Management - Fixed Income sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2022, closing a stake of 341,294 shares — an estimated $11.9M sold.

Mesirow Financial Investment Management - Fixed Income first reported a position in AMPH in Q1 2022 and held it in 2 quarters. The position peaked at $11.9M in Q2 2022. 207 funds tracked by Wall St. Rank hold AMPH as of Q3 2022.

  • Mesirow Financial Investment Management - Fixed Income reported no remaining Amphastar Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Mesirow Financial Investment Management - Fixed Income sold 341,294 Amphastar Pharmaceuticals shares in Q3 2022, an estimated $11.9M.
  • Mesirow Financial Investment Management - Fixed Income first reported a position in Amphastar Pharmaceuticals in Q1 2022 and held it in 2 quarters.
  • Mesirow Financial Investment Management - Fixed Income's Amphastar Pharmaceuticals position peaked at $11.9M in Q2 2022.
  • 207 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2022.

Based on Mesirow Financial Investment Management - Fixed Income's 13F filing for Q3 2022, filed 8 Nov 2022.